AETHLON MEDICAL, INC. (AEMD) Debt Components
- 2026-01-31: Debt Instrument, Interest Rate, Stated Percentagepure (m); Debt Instrument, Periodic PaymentUSD 1 month · $23.10K; Convertible Notes Payable, CurrentUSD (m); Notes Payable, CurrentUSD (m).
- 2026-01-31: Debt Instrument, Interest Rate, Stated Percentagepure 9.00%; Debt Instrument, Periodic PaymentUSD (m); Convertible Notes Payable, CurrentUSD (m); Notes Payable, CurrentUSD (m).
- 2022-03-31: Debt Instrument, Interest Rate, Stated Percentagepure (m); Debt Instrument, Periodic PaymentUSD (m); Convertible Notes Payable, CurrentUSD (m); Notes Payable, CurrentUSD (m).
- 2020-03-31: Debt Instrument, Interest Rate, Stated Percentagepure (m); Debt Instrument, Periodic PaymentUSD (m); Convertible Notes Payable, CurrentUSD $0.00; Notes Payable, CurrentUSD (m).
AETHLON MEDICAL, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Debt Instrument, Interest Rate, Stated Percentage pure | Debt Instrument, Periodic Payment USD | Convertible Notes Payable, Current USD | Notes Payable, Current USD | Convertible Notes Payable USD | Notes Payable USD | Debt Instrument, Interest Rate During Period pure | Debt Instrument, Convertible, Beneficial Conversion Feature USD | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-01-31 | (m) | 1 month · $23.10K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-01-31 | 9.00% | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · 25.00% | (m) | (m) |
| 2020-03-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | $892.59K | (m) | $892.59K | (m) | (m) | (m) | $0.00 |
| 2019-03-31 | (m) | (m) | $962.30K | (m) | $962.30K | (m) | (m) | (m) | $30.29K |
| 2018-12-31 | (m) | (m) | $932.01K | (m) | $932.01K | (m) | (m) | (m) | $60.58K |
| 2018-09-30 | (m) | (m) | $901.73K | (m) | $901.73K | (m) | (m) | (m) | $90.86K |
| 2018-06-30 | (m) | (m) | (m) | (m) | $871.44K | (m) | (m) | (m) | $121.15K |
| 2018-03-31 | (m) | (m) | $0.00 | (m) | $841.15K | (m) | (m) | (m) | $151.44K |
| 2017-12-31 | (m) | (m) | (m) | (m) | $810.87K | (m) | (m) | (m) | $181.72K |
| 2017-09-30 | (m) | (m) | (m) | (m) | $780.58K | (m) | (m) | (m) | $212.01K |
| 2017-06-30 | (m) | (m) | (m) | (m) | $1.05M | (m) | (m) | (m) | $242.30K |
| 2017-03-31 | (m) | (m) | (m) | (m) | $519.20K | (m) | (m) | (m) | $774.01K |
| 2016-12-31 | (m) | (m) | (m) | (m) | $414.40K | (m) | (m) | (m) | $928.81K |
| 2016-09-30 | (m) | (m) | $605.82K | (m) | $605.82K | (m) | (m) | (m) | $57.00K |
| 2016-06-30 | (m) | (m) | (m) | (m) | $616.82K | (m) | (m) | (m) | $75.99K |
| 2016-03-31 | (m) | (m) | (m) | (m) | $500.14K | (m) | (m) | (m) | $27.64K |
| 2016-03-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | $434.64K | (m) | $434.64K | (m) | (m) | (m) | $93.14K |
| 2015-09-30 | (m) | (m) | $341.50K | (m) | $341.50K | (m) | (m) | (m) | $186.28K |
| 2015-06-30 | (m) | (m) | $248.37K | (m) | $248.37K | (m) | (m) | (m) | $279.41K |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $372.55K |
| 2015-03-31 | (m) | (m) | $0.00 | (m) | $155.23K | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | $0.00 | $22.50K | (m) | (m) | (m) | (m) | $465.69K |
| 2014-09-30 | (m) | (m) | $483.42K | $190.00K | $1.47M | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | $482.65K | $390.00K | $1.48M | (m) | (m) | (m) | $0.00 |
| 2014-03-31 | (m) | (m) | $1.37M | $390.00K | $2.14M | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
| 2013-12-31 | (m) | (m) | $2.24M | $390.00K | $2.24M | $0.00 | (m) | (m) | $0.00 |
| 2013-09-30 | (m) | (m) | $2.24M | $590.00K | $2.24M | $0.00 | (m) | (m) | $-570.00 |
| 2013-06-30 | (m) | (m) | $2.26M | $235.30K | $2.26M | (m) | (m) | (m) | $-2.25K |
| 2013-03-31 | (m) | (m) | $2.37M | $321.38K | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | $2.37M | $360.19K | (m) | (m) | $-4.28K |
| 2012-12-31 | (m) | (m) | $2.39M | $370.02K | $2.40M | (m) | (m) | (m) | $-7.04K |
| 2012-09-30 | (m) | (m) | $2.39M | $452.11K | $2.40M | (m) | (m) | (m) | $-9.74K |
| 2012-06-30 | (m) | (m) | $2.88M | $490.00K | $2.97M | (m) | (m) | (m) | $-85.27K |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $792.88K | (m) |
| 2012-03-31 | (m) | (m) | $3.01M | $654.80K | $3.48M | (m) | (m) | (m) | $-471.44K |
| 2011-12-31 | (m) | (m) | $2.46M | $584.80K | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | $2.34M | $594.80K | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | $2.00M | $550.19K | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $90.34K | (m) |
| 2011-03-31 | (m) | (m) | $2.18M | $190.00K | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $6.98M | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $3.20M | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $3.20M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |